Down-regulation of μ-opioid receptor by full but not partial agonists is independent of G protein coupling

Molecular Pharmacology

Volumn 52, Issue 5, 1997, Pages 896-902

  Yabaluri, Nirmala ^a   Medzihradsky, Fedor ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Medical Science I ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA ENDORPHIN; BUTORPHANOL; CYCLIC AMP; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ETORPHINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALOXONE; NALTREXONE; PERTUSSIS TOXIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG TOLERANCE; GENE EXPRESSION; GLIA CELL; INTERNALIZATION; LIGAND BINDING; LONG TERM EXPOSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION;

EID: 0030733077     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.5.896     Document Type: Article

References (37)

1. Uhl, G. R., S. Childers, and G. Pasternak. An opiate-receptor gene family reunion. Trends Neurosci. 17:89-93 (1994).
2. Matthes, H. W. D., R. Maldonado, F. Simonin, O. Valverde, S. Slowe, I. Kitchen, K. Befort, A. Dierich, M. Le Meur, P. Dolle, E. Tzavara, J. Hanoune, B. P. Roques, and B. L. Kieffer. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid receptor gene. Nature (Lond.) 383:819-823 (1996).
3. Chang, K.-J., R. W. Eckel, and S. G. Blanchard. Opioid peptides induce reduction of enkephalin receptors in cultured neuroblastoma cells. Nature (Lond.) 296:446-448 (1982).
4. Law, P.-Y., D. S. Hom, and H. H. Loh. Opiate receptor down-regulation and desensitization in neuroblastoma-glioma NG 108-15 hybrid cells are two separate cellular adaptation processes. Mol. Pharmacol. 24:413-424 (1983).
5. Sharma, S. K., W. A. Klee, and M. Nirenberg. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA 72:3092-3096 (1975).
6. Puttfarcken, P. S., and B. M. Cox. Morphine-induced desensitization and down-regulation at mu-receptors in 7315C pituitary tumor cells. Life Sci. 45:1937-1942 (1989).
7. Carter, B. D., and F. Medzihradsky. Receptor tolerance mechanisms of opioid tolerance in SH-SY5Y human neural cells. Mol. Pharmacol. 43:465-473 (1993).
8. Zadina, J. E., S. L. Chang, L.-J. Ge, and A. J. Kastin. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 265:254-262 (1993).
9. Murphy, S., and B. Pearce. Functional receptors for neurotransmitters on astroglial cells. Neuroscience 22:381-394 (1987).
10. 6 glioma cells. J. Neurochem. 64(suppl.):S104B (1995).
11. 6 glioma cell line expressing the mu opioid receptor. J. Pharmacol. Exp. Ther. 278:1121-1127 (1996).
12. Yabaluri, N., and F. Medzihradsky. Regulation of μ opioid receptor in neural cells by extracellular sodium. J. Neurochem. 68:1053-1061(1997).
13. Lowry, O. H., N. J. Rosenbough, A. L. Farr, and R. J. Randall. Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
14. Vaachon, L., T. Costa, and A. Herz. Opioid receptor desensitization in NG 108-15 cells. Biochem. Pharmacol. 36:2889-2897 (1987).
15. Yu, V. C., S. Eiger, D.-S. Duan, J. Lameh, and W. Sadee. Regulation of cyclic AMP by the μ-opioid receptor in human neuroblastoma SH-SY5Y cells. J. Neurochem. 55:1390-1396 (1990).
16. Werling, L. L., P. N. McMahon, and B. M. Cox. Selective changes in μ opioid receptor properties induced by chronic morphine exposure. Proc. Natl. Acad. Sci. USA 86:6393-6397 (1989).
17. Ammer, H., and R. Schultz. Alterations in the expression of G proteins and regulation of adenylate cyclase in human neuroblastoma SH-SY5Y cells chronically exposed to low-efficacy μ-opioids. Biochem. J. 295:263-271 (1993).
18. Pittman, R., E. E. Reynolds, and P. B. Molinoff. Relationship between intrinsic activities of agonists in normal and desensitized tissue and agonist-induced loss of beta adrenergic receptors. J. Pharmacol. Exp. Ther. 230:614-618 (1984).
19. Sternini, C., M. Spann, B. Anton, D. E. Keith, Jr., N. W. Bunnett, M. V. Zastrow, C. Evans, and N. C. Brecha. Agonist-selective endocytosis of μ opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. USA 93:9241-9246 (1996).
20. Zadina, J. E., A. J. Kastin, L. M. Harrison, L.-J. Ge, and S. L. Chang. Opiate receptor changes after chronic exposure to agonists and antagonists. Ann. N. Y. Acad. Sci. 757:353-361 (1995).
21. 35S]GTPγS autoradiography in rat brain. J. Neurosci. 16:2684-2692 (1996).
22. Collier, H. O. J., and D. L. Francis. Morphine abstinence is associated with increased brain cyclic AMP. Nature (Lond.) 255:159-162 (1975).
23. Crain, S. M., and K-F. Shen. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol. Sci. 11:77-81 (1990).
24. Avidor-Reiss, T., M. Bayewitch, R. Levy, N. Matus-Leibovitch, I. Nevo, and Z. Vogel. Adenylyl cyclase supersensitization in μ-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J. Biol. Chem. 270:29732-29738 (1995).
25. Matsuoka, I., R. Maldonado, N. Defer, F. Noel, J. Hanoune, and B.-P. Roques. Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA. Eur. J. Pharmacol. 268:215-221 (1994).
26. Tota, M. R., and M. I. Schimerlik. Partial agonist effects on the interaction between the atrial muscarinic receptor and the inhibitory guanine nucleotide-binding protein in a reconstituted system. Mol. Pharmacol. 37:996-1004 (1990).
27. Benovic, J. L., M. Bouvier, M. G. Caron, and R. J. Lefkowitz. Regulation of adenylyl cyclase-coupled beta-adrenergic receptor. Annu. Rev. Cell Biol. 4:405-428 (1988).
28. 2-adrenergic receptor. J. Biol. Chem. 268: 4625-4636 (1993).
29. Keith, D. E., S. R. Murray, P. A. Zaki, P. C. Chu, D. V. Lissin, L. Kang, C. J. Evans, and M. Zastrow. Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271:19021-19024 (1996).
30. Arden, J. R., V. Segredo, Z. Wang, J. Lameh, and W. Sadee. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cells. J. Neurochem. 65:1636-1645 (1995).
31. Ferguson, S. S. G., W. E. Downey III, A.-M. Colapietro, L. S. Barak, L. Menard, and M. G. Caron. Role of β-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science (Washington D. C.) 271:363-366 (1996).
32. Nestler, E. J., and J. F. Tallman. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus ceruleus. Mol. Pharmacol. 33:127-132 (1988).
33. Busquets, X., P. V. Escriba, M. Sastre, and J. A. Garcia-Sevilla. Loss of protein kinase C-αβ in brain of heroin addicts and morphine-dependent rats. J. Neurochem. 64:247-252 (1995).
34. Terwilliger, R. Z., J. Ortiz, X. Guitart, and E. J. Nestler. Chronic morphine administration increases β-adrenergic receptor kinase (βARK) levels in the rat locus coeruleus. J. Neurochem. 63:1983-1986 (1994).
35. Cvejic, S., N. Trapaidze, C. Cyr, and L. A. Devi. Thr353, located within the COOH-terminal tail of the δ opiate receptor, is involved in receptor down-regulation. J. Biol. Chem. 271:4073-4076 (1996).
36. Law, P.-Y., A. K. Louie, and H. H. Loh. Effect of pertussis toxin treatment on the down-regulation of opiate receptors in neuroblastoma-glioma NG 108-15 hybrid cells. J. Biol. Chem. 260:14818-14823 (1985).
37. 2-adrenergic receptors after inactivation of Ni by pertussis toxin. Endocrinology 119:1305-1314 (1986).